{"name":"Per-Ola Carlsson","slug":"per-ola-carlsson","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Metabolic","slug":"metabolic","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Placebo for liraglutide","genericName":"Placebo for liraglutide","slug":"placebo-for-liraglutide","indication":"Control arm in clinical trials for liraglutide (GLP-1 receptor agonist for type 2 diabetes and obesity)","status":"marketed"}]}],"pipeline":[{"name":"Placebo for liraglutide","genericName":"Placebo for liraglutide","slug":"placebo-for-liraglutide","phase":"marketed","mechanism":"A placebo contains no active pharmaceutical ingredient and produces no direct pharmacological effect.","indications":["Control arm in clinical trials for liraglutide (GLP-1 receptor agonist for type 2 diabetes and obesity)"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi0AFBVV95cUxORTBWT1dDTjk1R3dFLUtCamlVQUFuaVFjd2J5R25rT0l3eUd1UjQtN21JQml6M2NobHhZMVlPNkFhRTI2VzlEQ29zaVZheDFWcWRQRVFmQWZEbm84dkxmRkwtVVF6cUx2WE1BODNlQll5clU5dWVIZkI3SmtBb01MVlVaV0UwdzdUM2VmMVg4TEpHcHNwYmUxVlRYLUZ3MnYwMWFNQTd3YXNENi03LTV1eDc1NmxPdWFQZlpxVEN4cmgyQXQ4OWlPWUh1TDBYMDdP?oc=5","date":"2026-03-16","type":"pipeline","source":"European Pharmaceutical Review","summary":"Sana's islet cell transplant therapy shows early promise in type 1 diabetes - European Pharmaceutical Review","headline":"Sana's islet cell transplant therapy shows early promise in type 1 diabetes","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxNdTRsOEx3b3ZYM0RER3hHNWkyOURqbHVfbEpPTnJQNEJNRFJscm1XbVBLbV9XcDN2T3IwMV9DejRYUTJ5bjlVRG9GMElrMjBTTlM2MEd4WlFGZm9nS3JMd0ZCTUc5TGFhRkpPaHZjbnZRV3gtRkdoWWpfZEVFNjNHcWpMRllkSHhFeWREM0loUEZqRG9tUlFMdklYZUhJS0dfaXVjZ25R?oc=5","date":"2026-03-16","type":"pipeline","source":"Breakthrough T1D","summary":"ATTD 2026 Days 3 and 4 – Breakthroughs Transforming T1D - Breakthrough T1D","headline":"ATTD 2026 Days 3 and 4 – Breakthroughs Transforming T1D - Breakthrough T1D","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE04MkhZOUJYekFQY0hOVEk4UnVLQ2FCOWdsTmRHcEtpRmVZclE5OHQyd19panE1S0JjZzJSR19EcWJ0YXM0eDNxTjN1TXZuRTBRcDg0?oc=5","date":"2026-03-13","type":"pipeline","source":"FirstWord Pharma","summary":"More than a year after transplant, Sana's islet cell therapy is still going strong - FirstWord Pharma","headline":"More than a year after transplant, Sana's islet cell therapy is still going strong","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxNR2pnd2FrbHhKTEpzbVpSYV9MVjlSYm5WNWc5cWpVVklQWXZ2QzNOMzhsSGFZZGZnU1NBbURoUmhJSDhGODF0czZ1TVpJUUJVLUNlX0lWc01qQjkycDRYMHNzZ3dLYjJLYzdLMzh0R1NwMXljMzVabnZic1ZUZURuVVVmZEZKZlI3czRrRHo5Q1JxRkhELTRKd1NjdEhhb2VGb3I0cW41RzFsSWVfNHkxTkdjbnhXOUUxRnNmRQ?oc=5","date":"2026-03-04","type":"pipeline","source":"C&EN","summary":"Gene-modified pancreas cells offer hope for people with type 1 diabetes - C&EN","headline":"Gene-modified pancreas cells offer hope for people with type 1 diabetes - C&EN","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwwFBVV95cUxQWHd5NWhndzhGWXRsMWIybGxsNkdqNDJWMFd6bWkxQ2MzTmE2Z3V0RnNfWTh6aXZ6UE14MzNEdW5GdU5Xb2tLZzVXVDFuWjhXcGdoSHJuVG42ZF9xZ0YxZDJwTGduaDYtOXJNU0lCZS1qcC1Pak9JOV8xVTVfVl9CWkk0eDlORXY1cDk2ZEVFMUVVSnFzeGJJbjQ0MkpObWVXRDFWek5rQUYxZEhQYWRuYVJrM2x5MDRMNkVidTREbXJiS1E?oc=5","date":"2025-11-19","type":"pipeline","source":"uu.se","summary":"Prestigious award for Per-Ola Carlsson – Disciplinary Domain of Medicine and Pharmacy - uu.se","headline":"Prestigious award for Per-Ola Carlsson – Disciplinary Domain of Medicine and Pharmacy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi-AFBVV95cUxQRjJGODRvd2xQb1FHUXZWWkNtTHFxVlAzRE40WFpaejdLOFF5M0w1dm5XNU1WeHNiTVVKS1F2S3ZvcE44Vk95YUNSX2pPalJGZmxJSE15aW5fWWxkWUhWT1R3R2hRRlRvbzlYclNEYmJGSjVQUWdrVVZXSGcyYTZpUkNweWRDLUpSWkhVV2ZWdUctRHFoY3lkU1A5UktJZVZlWk5MTEhNVzFPdVlteHNTdUdhODZhelRPaGdHdTBYajRYTV9tQXBsOXZ1TlVLeXVRQ25xbVgwV1VaN0xobVREWFdTcW92T3JiV2NnbzJINm05QTZtV19lV9IB_gFBVV95cUxNOHhtZVNybmpKMmVYZmlkTHU1Q3RPaXZ4ME1EWGR4Y2JQSVVfVTkyRlRuME5tb2NpODkzc3dfamllaGkwYS1nV2RjME1tU1I3V0RYUjhwR3g4ckxpcGd1dHVPS2kzVWc2VDdVU3d3SFZqRTl6cUQ1UG84WlZpZVBJRURwRG5SckRtbGh6bXFuWDdoWFVrODVVTkwtTEs1LUotRUhQZXdNR3RHdzRjUlg2dWNteWVKRk1Va2x2QjYxZUsxVmZSb0hRZEVIOGJmNG9tem01UzA0Ti1lNnRLUDdHdnZBOXc3YWZCNFpMRFB4SmRTaFFHYi15S1BYd2dEQQ?oc=5","date":"2025-11-12","type":"pipeline","source":"The Times of India","summary":"Type 1 diabetes closer to a cure as patient makes his own insulin - The Times of India","headline":"Type 1 diabetes closer to a cure as patient makes his own insulin","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiyAFBVV95cUxONmd3U3pLai1WR2hBWGlsQlQtbTd0alRuVUc0M0Uza2h3VU1NUm11YmtUSW90YlY2eDV3UzkxZlRDM1A0T1lIenpZOUVSMEYwSGpTYjRKSGY0a1k3N0pIbzJva2RRUDdYbEZ2V2RuaXpkVDhZVV90RE1xcG5MSGhHVDlwWmhmTnBZY0ROQ0dXSGQ4WVJtTlEtSjh6OGljMjd1enFyekdYbFcyOVdnR2o1S2ZFRll1Qll5QWdDUUkybjNmTUNDN1lSNw?oc=5","date":"2025-10-08","type":"pipeline","source":"uu.se","summary":"Diabetes the theme of the Olof Rudbeck Day – Disciplinary Domain of Medicine and Pharmacy - uu.se","headline":"Diabetes the theme of the Olof Rudbeck Day – Disciplinary Domain of Medicine and Pharmacy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2wFBVV95cUxQbC10U3BwUmloZnJySHNqdGRUTXFHM29Ea3Q1TjdkUUVrMWxCLUgyd3REaWZtZ19icGJPdlY0VUhuaU9jZzJuekNIczZoRkRza1NqUEZJRTM0bmRFakNxcmNvQzh4QjlCXzA5b1pZZmhrc2hFMUdWaGgzaGoyYmxQSm9McnVmVnlNRVhTZWpoaXQ0QmhFS1BMLTBDNFV0UnYxdU9ncjBkdDh2bEEtUE9UUUtyX0lodDNxaXN3VFl5RHRITXRWczJ1OTFiZ1huaFR3ZXNvS01WdVJzQzQ?oc=5","date":"2025-09-15","type":"pipeline","source":"ki.se","summary":"Development of cell therapy drug treatments - ki.se","headline":"Development of cell therapy drug treatments","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE9HaDBWaWEwbXhiYnlJSS1LRnlRQkNySExSbVpaTjZMZnhUbk5lZzZGdWtvVGZSYXpId0R5OGxuV2FnU0ExeXg5NzhUTUFQRVdUTXl0UExqYTJ3QXFwTHZr?oc=5","date":"2025-08-04","type":"pipeline","source":"NEJM","summary":"Survival of Transplanted Allogeneic Beta Cells with No Immunosuppression - NEJM","headline":"Survival of Transplanted Allogeneic Beta Cells with No Immunosuppression","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMicEFVX3lxTE8taHk0eUdDWUZmblZOUWRGWTNoQXc4TG42ZDdacHdFZmNlN1RjX0s4bktLT2c2WUpwUkJtci11WjRDZnI2VE9zNkUwbjJSNHR4STNQamxWZlRqZG9DWWpBYzRCQnYyZUU5UVo4UFZpU2U?oc=5","date":"2025-08-04","type":"pipeline","source":"MedPage Today","summary":"Novel T1D Therapy Opens the Door to Cell Transplants Sans Immunosuppressants - MedPage Today","headline":"Novel T1D Therapy Opens the Door to Cell Transplants Sans Immunosuppressants","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwAJBVV95cUxQLU9UYTI5MXVEdHpoc2F1N0liMk53OHItMkxURTVDVVM4VHlMNnlvVVZWc19CRFVET0FMZmJpXzFrSFpRMmlaMUIzdmxDMWkyQzFxMDh2cFdQZGYtOGZrOUV1OG04RFFNVEo2VzRsQUVkTTAtemtkbXR0T0JWWU52LWN5MEFZdW5VQzBlSlBEdHhabjJYOGJTT2drTkxDTVY5cWlRMXZFcDBRZEJVTklUc2ROTUdPbWZaMndOc2JreFRLLVZaa2RxSzJJLU1YeUVJZHp4a2p0TnduMG5OMXc2d0xrZnRPZWE1RGltLS1OeGlrb0VBNTBxelF5aDNWZ0FUNDBYUUVvaENJOXhtSXlIZGdfUGZ0WTZWOHZ4RGpZNTlUcVJwQ202SWM2VTZOLXVsdlhtR2JWT3U1M2VRZnItcQ?oc=5","date":"2025-06-23","type":"pipeline","source":"GlobeNewswire","summary":"Sana Biotechnology Announces Positive Six-Month Clinical - GlobeNewswire","headline":"Sana Biotechnology Announces Positive Six-Month Clinical","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxPLVlVa1U5YUxzMW5VWndlcENidXIxX3M1N3JGRlJqLXNxc1ZpZ0dTcW83dC1pNGxrcDBYWXRNYTFRc1Jfbk5XZDVrTXo1YTd1M28zN0ZjTkw4dzNISnA2QVlubENTMUhXb3EyNVlieUlDcVQ2TnVtanNkRG1kWldIX0xYMTdOREpYanhJSTBITldidw?oc=5","date":"2024-06-03","type":"pipeline","source":"Frontiers","summary":"Pancreatic islet transplantation: current advances and challenges - Frontiers","headline":"Pancreatic islet transplantation: current advances and challenges","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"marketed":1},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}